|
Volumn 36, Issue 4, 2004, Pages 1121-1122
|
Islet of langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
FRUCTOSAMINE;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
RAPAMYCIN;
STEROID;
TACROLIMUS;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE CLEARANCE;
FEMALE;
FOLLOW UP;
GRAFT FAILURE;
GRAFT REJECTION;
HUMAN;
INFUSION;
INSULIN DEPENDENT DIABETES MELLITUS;
INTERSTITIAL PNEUMONIA;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
LANGERHANS CELL;
MALE;
NEPHROTOXICITY;
PANCREAS ISLET;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
SEX DIFFERENCE;
SIDE EFFECT;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
UNIVERSITY;
ADULT;
ANTIBODIES, MONOCLONAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
ISLETS OF LANGERHANS TRANSPLANTATION;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
SIROLIMUS;
SWITZERLAND;
TACROLIMUS;
TREATMENT OUTCOME;
|
EID: 2942633635
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.04.027 Document Type: Conference Paper |
Times cited : (19)
|
References (3)
|